UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Steatosis: co-factor in other liver diseases

Hepatology (Baltimore, Md.), 2005-07, Vol.42 (1), p.5-13

2005

Volltextzugriff (PDF)

Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data

Gastroenterology (New York, N.Y. 1943), 2006-05, Vol.130 (6), p.1636-1642

2006

Volltextzugriff (PDF)

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered

Journal of hepatology, 2009-08, Vol.51 (2), p.389-397

2009

Volltextzugriff (PDF)

Magnetic resonance imaging and spectroscopy for monitoring liver steatosis

Journal of magnetic resonance imaging, 2008-10, Vol.28 (4), p.937-945

2008

Volltextzugriff (PDF)

Interleukin‐32: A new proinflammatory cytokine involved in hepatitis C virus‐related liver inflammation and fibrosis

Hepatology (Baltimore, Md.), 2011-06, Vol.53 (6), p.1819-1829

2011

Volltextzugriff (PDF)

Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C

Hepatology (Baltimore, Md.), 2008-07, Vol.48 (1), p.80-87

2008

Volltextzugriff (PDF)

Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways

Liver international, 2013-04, Vol.33 (4), p.624-632

2013

Volltextzugriff (PDF)

Hepatic progenitor cell–mediated regeneration and fibrosis: Chicken or egg?

Hepatology (Baltimore, Md.), 2009-05, Vol.49 (5), p.1424-1426

2009

Volltextzugriff (PDF)

Macrophage secretory products induce an inflammatory phenotype in hepatocytes

World journal of gastroenterology : WJG, 2012-04, Vol.18 (15), p.1732-1744

2012

Volltextzugriff (PDF)

Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injury

Hepatology (Baltimore, Md.), 2004-05, Vol.39 (5), p.1230-1238

2004

Volltextzugriff (PDF)

Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis

Journal of hepatology, 2008-12, Vol.49 (6), p.1046-1054

2008

Volltextzugriff (PDF)

Metabolic Factors and Non-Alcoholic Fatty Liver Disease as Co-Factors in Other Liver Diseases

Digestive diseases (Basel), 2010-01, Vol.28 (1), p.186-191

2010

Volltextzugriff (PDF)

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

Nature communications, 2016-09, Vol.7 (1), p.12757-12757, Article 12757

2016

Volltextzugriff (PDF)

Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction

Gastroenterology (New York, N.Y. 1943), 2007-07, Vol.133 (1), p.80-90

2007

Volltextzugriff (PDF)

Fibrosis correlates with a ductular reaction in hepatitis C : Roles of impaired replication, progenitor cells and steatosis

Hepatology (Baltimore, Md.), 2005-04, Vol.41 (4), p.809-818

2005

Volltextzugriff (PDF)

Steatosis as a Cofactor in Other Liver Diseases: Hepatitis C Virus, Alcohol, Hemochromatosis, and Others

Clinics in liver disease, 2007-02, Vol.11 (1), p.173-189

2007

Volltextzugriff (PDF)

Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease

Annals of internal medicine, 2005-11, Vol.143 (10), p.753

2005

Volltextzugriff (PDF)

The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis

Liver international, 2012-10, Vol.32 (9), p.1391-1399

2012

Volltextzugriff (PDF)

Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C

Liver international, 2013-04, Vol.33 (4), p.569-579

2013

Volltextzugriff (PDF)

Interleukin‐10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

Hepatology (Baltimore, Md.), 1999-08, Vol.30 (2), p.526-530

1999

Volltextzugriff (PDF)

Virus‐specific CD8+ T lymphocytes within the normal human liver

European journal of immunology, 2004-06, Vol.34 (6), p.1526-1531

2004

Volltextzugriff (PDF)

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy

Journal of hepatology, 2003-12, Vol.39 (6), p.1042-1048

2003

Volltextzugriff (PDF)

Host genetic factors influence disease progression in chronic hepatitis C

Hepatology (Baltimore, Md.), 2000-04, Vol.31 (4), p.828-833

2000

Volltextzugriff (PDF)

Angiotensin-Converting Enzyme Inhibition Attenuates the Progression of Rat Hepatic Fibrosis

Gastroenterology (New York, N.Y. 1943), 2001-07, Vol.121 (1), p.148-155

2001

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(101)
Berichte
(1)

Sprache

Englisch
(102)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Humans
(70)
Life Sciences & Biomedicine
(66)
Male
(49)
Female
(48)
Adult
(36)
Middle Aged
(36)
Gastroenterology & Hepatology
(35)
Biological And Medical Sciences
(29)
Medical Sciences
(29)
Liver - Pathology
(15)
Fibrosis
(14)
Hepatitis C, Chronic - Pathology
(13)
Liver Cirrhosis - Pathology
(13)
Cohort Studies
(12)
Gastroenterology. Liver. Pancreas. Abdomen
(12)
Hepatitis C
(11)
Fatty Liver - Pathology
(10)
Genotype
(10)
Hepatitis C, Chronic - Complications
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Steatosis: co-factor in other liver diseases

Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered

Magnetic resonance imaging and spectroscopy for monitoring liver steatosis

Interleukin‐32: A new proinflammatory cytokine involved in hepatitis C virus‐related liver inflammation and fibrosis

Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C

Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways

Hepatic progenitor cell–mediated regeneration and fibrosis: Chicken or egg?

Macrophage secretory products induce an inflammatory phenotype in hepatocytes

Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injury

Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis

Metabolic Factors and Non-Alcoholic Fatty Liver Disease as Co-Factors in Other Liver Diseases

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction

Fibrosis correlates with a ductular reaction in hepatitis C : Roles of impaired replication, progenitor cells and steatosis

Steatosis as a Cofactor in Other Liver Diseases: Hepatitis C Virus, Alcohol, Hemochromatosis, and Others

Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease

The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C

Interleukin‐10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

Virus‐specific CD8+ T lymphocytes within the normal human liver

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy

Host genetic factors influence disease progression in chronic hepatitis C

Angiotensin-Converting Enzyme Inhibition Attenuates the Progression of Rat Hepatic Fibrosis

Suchergebnisse filtern